✦ LIBER ✦
C0149 Long-term treatment of venous thromboembolism, with moderate-intensity vitamin-k antagonists (VKA) (INR range between 1.8 - 2.5), improve patient comfort and decreases treatment costs, without increasing adverse effects: A matched paired study
✍ Scribed by Casals Solé, Francesc J.
- Book ID
- 123536701
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 66 KB
- Volume
- 130
- Category
- Article
- ISSN
- 0049-3848
No coin nor oath required. For personal study only.